Schizophrenia and Injection site cellulitis

Summary:

Injection site cellulitis is found among people with Schizophrenia, especially for people who are male, 20-29 old.

The study analyzes which people have Injection site cellulitis with Schizophrenia. It is created by eHealthMe based on reports of 16 people who have Schizophrenia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Schizophrenia?

Schizophrenia (a mental disorder characterized by a breakdown of thought processes) is found to be associated with 512 drugs and 725 conditions by eHealthMe. Check the latest studies of Schizophrenia.

What is Injection site cellulitis?

Injection site cellulitis (injection site inflammation) is found to be associated with 170 drugs and 306 conditions by eHealthMe. Check the latest studies of Injection site cellulitis.



On Jul, 31, 2026

16 people who have Schizophrenia and Injection Site Cellulitis are studied.

Would you have Injection site cellulitis when you have Schizophrenia?

Gender of people who have Schizophrenia and experienced Injection Site Cellulitis *:

  • female: 40 %
  • male: 60 %

Age of people who have Schizophrenia and experienced Injection Site Cellulitis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 7.69 %
  • 20-29: 46.15 %
  • 30-39: 7.69 %
  • 40-49: 7.69 %
  • 50-59: 30.77 %
  • 60+: 0.0 %

Common co-existing conditions for these people *:

  1. Stress And Anxiety: 1 person, 6.25%
  2. Schizophrenia, Disorganised Type (speech and behaviour that are disorganized or difficult to understand): 1 person, 6.25%
  3. Schizoaffective Disorder (a mental disorder characterized by disordered thought): 1 person, 6.25%
  4. Obsessive-Compulsive Disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;): 1 person, 6.25%
  5. Ill-Defined Disorder: 1 person, 6.25%
  6. Diabetes: 1 person, 6.25%
  7. Birth Control: 1 person, 6.25%
  8. Bipolar Disorder (mood disorder): 1 person, 6.25%
  9. Asthma: 1 person, 6.25%

Common drugs taken by these people *:

  1. Invega Sustenna: 12 people, 75.00%
  2. Invega: 4 people, 25.00%
  3. Ativan: 2 people, 12.50%
  4. Yasmin: 1 person, 6.25%
  5. Constulose: 1 person, 6.25%
  6. Albuterol: 1 person, 6.25%
  7. Celexa: 1 person, 6.25%
  8. Clonazepam: 1 person, 6.25%
  9. Clozapine: 1 person, 6.25%
  10. Clozaril: 1 person, 6.25%

Common symptoms for these people *:

  1. Regressive Behavior: 3 people, 18.75%
  2. Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur): 3 people, 18.75%
  3. Pain In Extremity: 3 people, 18.75%
  4. Injection Site Erythema (redness at injection site): 3 people, 18.75%
  5. Fatigue (feeling of tiredness): 3 people, 18.75%
  6. Injection Site Reaction: 2 people, 12.50%
  7. Staphylococcal Infection (an infection with staphylococcus bacteria): 1 person, 6.25%
  8. Rashes (redness): 1 person, 6.25%
  9. Pain: 1 person, 6.25%
  10. Memory Loss: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Injection site cellulitis?

- Check whether Injection site cellulitis is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Injection site cellulitis:

All the conditions that are associated with Injection site cellulitis:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Injection site cellulitis and Schizophrenia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: